SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-028948
Filing Date
2021-02-26
Accepted
2021-02-26 13:21:58
Documents
1
Period of Report
2021-02-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm218062d1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm218062d1_4seq1.xml 4 8388
  Complete submission text file 0001104659-21-028948.txt   9849
Mailing Address 888 SEVENTH AVENUE 9TH FLOOR NEW YORK NY 10106
Business Address
Greenspan Ira Scott (Reporting) CIK: 0001449211 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39788 | Film No.: 21686692

Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Issuer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations